Download Full Text (260 KB)
- Proteomics May One Day Revolutionize Cancer Detection, Staging, and Prognosis
- Depression in Patients with Cancer Is a Separate—and Treatable—Illness
- House Call: Facing Fatigue When You Have Cancer: What Can You Do?
- DiaLog: Proteomics: The Creation of a New Field of Study, by Ryuji Kobayashi, PhD, Professor, Department of Molecular Pathology, Director, Proteomics Program
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
The University of Texas MD Anderson Cancer Center
Mills, Gordon B.; Gutstein, Howard; Hamilton, Stanley R.; Arap, Wadih; Pasqualini, Renata; Kobayashi, Ryuki; Sherman, Laura; Fisch, Michael J., 1964-; Sivesind, Debra M.; Proteomics; Ovarian Neoplasms; Biomarkers, Tumor; Colorectal Neoplasms; Colonoscopy; Prostate-Specific Antigen; Depression; Selective Serotonin Reuptake Inhibitors; Antidepressive Agents, Tricyclic; Central Nervous System Stimulants; Amphetamines; Complementary Therapies; Imagery, Psychotherapy; Patients; Fatigue; Mass Spectrometry; Proteins -- chemistry; Prostatic Neoplasms.
History of Science, Technology, and Medicine | Oncology
Matias, Katie Prout; Galloway, David; and Kobayashi, Ryuji PhD, "OncoLog, Volume 48, Number 05, May 2003" (2003). OncoLog MD Anderson's Report to Physicians (All issues). 113.
Conditions Governing Access